title: The design of a randomized, placebo-controlled trial of celecoxib in preprostatectomy men with clinically localized adenocarcinoma of the prostate.
authors.affiliation: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA. heathel@jhmi.edu
authors.forename: Elisabeth I
authors.initials: EI
authors.lastname: Heath
authors.forename: Theodore L
authors.initials: TL
authors.lastname: DeWeese
authors.forename: Alan W
authors.initials: AW
authors.lastname: Partin
authors.forename: Angelo M
authors.initials: AM
authors.lastname: De Marzo
authors.forename: John D
authors.initials: JD
authors.lastname: Groopman
authors.forename: William G
authors.initials: WG
authors.lastname: Nelson
authors.forename: Steven A
authors.initials: SA
authors.lastname: Piantadosi
authors.forename: Ron
authors.initials: R
authors.lastname: Lieberman
authors.forename: Michael A
authors.initials: MA
authors.lastname: Carducci
mesh_terms: D000230:Adenocarcinoma / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000032:analysis; D000068579:Celecoxib; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use*; D004311:Double-Blind Method; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D011720:Pyrazoles; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D012107:Research Design; D013449:Sulfonamides / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D016861:Cyclooxygenase Inhibitors; D011720:Pyrazoles; D013449:Sulfonamides; D000068579:Celecoxib